Preclinical Strategy to Reduce Clinical Hepatotoxicity Using in Vitro Bioactivation Data for >200 Compounds

药理学 药品 谷胱甘肽 化学 药物代谢 药物开发 医学 生物化学
作者
Melanie Z. Sakatis,Melinda J. Reese,Andrew W. Harrell,Maxine Taylor,Ian A. Baines,Liangfu Chen,Jackie C. Bloomer,Eric Yang,Harma Ellens,Jeffrey L. Ambroso,Cerys A. Lovatt,Andrew D. Ayrton,Stephen E. Clarke
出处
期刊:Chemical Research in Toxicology [American Chemical Society]
卷期号:25 (10): 2067-2082 被引量:107
标识
DOI:10.1021/tx300075j
摘要

Drug-induced liver injury is the most common cause of market withdrawal of pharmaceuticals, and thus, there is considerable need for better prediction models for DILI early in drug discovery. We present a study involving 223 marketed drugs (51% associated with clinical hepatotoxicity; 49% non-hepatotoxic) to assess the concordance of in vitro bioactivation data with clinical hepatotoxicity and have used these data to develop a decision tree to help reduce late-stage candidate attrition. Data to assess P450 metabolism-dependent inhibition (MDI) for all common drug-metabolizing P450 enzymes were generated for 179 of these compounds, GSH adduct data generated for 190 compounds, covalent binding data obtained for 53 compounds, and clinical dose data obtained for all compounds. Individual data for all 223 compounds are presented here and interrogated to determine what level of an alert to consider termination of a compound. The analysis showed that 76% of drugs with a daily dose of <100 mg were non-hepatotoxic (p < 0.0001). Drugs with a daily dose of ≥100 mg or with GSH adduct formation, marked P450 MDI, or covalent binding ≥200 pmol eq/mg protein tended to be hepatotoxic (∼ 65% in each case). Combining dose with each bioactivation assay increased this association significantly (80–100%, p < 0.0001). These analyses were then used to develop the decision tree and the tree tested using 196 of the compounds with sufficient data (49% hepatotoxic; 51% non-hepatotoxic). The results of these outcome analyses demonstrated the utility of the tree in selectively terminating hepatotoxic compounds early; 45% of the hepatotoxic compounds evaluated using the tree were recommended for termination before candidate selection, whereas only 10% of the non-hepatotoxic compounds were recommended for termination. An independent set of 10 GSK compounds with known clinical hepatotoxicity status were also assessed using the tree, with similar results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
鱼憨儿完成签到,获得积分10
刚刚
幸福的含雁完成签到,获得积分10
1秒前
努力科研的小白完成签到 ,获得积分10
1秒前
sci审稿员完成签到,获得积分10
2秒前
2秒前
3秒前
你不要管完成签到 ,获得积分10
3秒前
4秒前
汉堡包应助juaner采纳,获得10
5秒前
fjnm发布了新的文献求助10
5秒前
6秒前
XQZ发布了新的文献求助10
6秒前
7秒前
8秒前
杪夏二八完成签到 ,获得积分10
9秒前
自信谷冬发布了新的文献求助10
9秒前
9秒前
咖可乐完成签到,获得积分10
9秒前
奕苼发布了新的文献求助10
10秒前
ironsilica完成签到,获得积分10
10秒前
HJJHJH发布了新的文献求助10
12秒前
12秒前
12秒前
666plus完成签到,获得积分10
13秒前
lingzhi发布了新的文献求助10
13秒前
fjnm完成签到,获得积分10
14秒前
脑洞疼应助Luyao采纳,获得10
14秒前
15秒前
平常的毛衣完成签到,获得积分10
15秒前
邓佳鑫Alan应助HJJHJH采纳,获得20
15秒前
曾经的千柔完成签到,获得积分10
15秒前
绿兔子完成签到,获得积分10
16秒前
16秒前
非哲完成签到 ,获得积分10
17秒前
无花果应助hechunmei采纳,获得10
17秒前
18秒前
zz发布了新的文献求助10
18秒前
Jasper应助羽化成仙采纳,获得10
18秒前
HQ完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6022202
求助须知:如何正确求助?哪些是违规求助? 7640450
关于积分的说明 16168441
捐赠科研通 5170272
什么是DOI,文献DOI怎么找? 2766727
邀请新用户注册赠送积分活动 1749945
关于科研通互助平台的介绍 1636817